Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997
Titel:
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997
Auteur:
Cripe, Larry D. Rader, Kevin Tallman, Martin S. Gordon, Michael S. Paietta, Elisabeth Bennett, John Neuberg, Donna Litzow, Mark R. O’Brien, Timothy E. Rowe, Jacob M.